We have compiled a list of manufacturers, distributors, product information, reference prices, and rankings for Hemophilia medications.
ipros is IPROS GMS ・ IPROS One of the largest technical database sites in Japan that collects information on.

Hemophilia medications - List of Manufacturers, Suppliers, Companies and Products | IPROS GMS

Hemophilia medications Product List

1～4 item / All 4 items

Displayed results
[Market Report] Global Market for Hemophilia Treatment

[Market Report] Global Market for Hemophilia Treatment

World Market for Hemophilia Treatment: Advances in medical therapies that enhance patient quality of life in the management of this rare bleeding disorder.

The global hemophilia treatment market is making significant progress as advancements in medical therapies innovate the management of this rare bleeding disorder. Hemophilia is a condition caused by genetic factors that impairs the blood's ability to clot properly, leading to prolonged bleeding times and an increased risk of severe bleeding symptoms. However, the emergence of innovative treatments has allowed patients to experience improved outcomes and enhanced quality of life. According to the latest market report, the global hemophilia treatment market reached $12.8 billion in 2021, with a steady growth forecast of a compound annual growth rate (CAGR) of 6.3% from 2022 to 2030. You can check the application method by clicking the [PDF Download] button or apply directly through the related links.

  • others
  • Hemophilia medications

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Treatment of Factor VIII Deficiency

[Research Material] The Global Market for Treatment of Factor VIII Deficiency

World Market for Treatment of Factor VIII Deficiency: Hemophilia A Drugs, Hemophilia A Inhibitor Treatment, von Willebrand Disease Treatment, Hospitals, Clinics, Others

This research report (Global Factor VIII Deficiency Treatment Market) investigates and analyzes the current status and outlook for the global market for Factor VIII deficiency treatment over the next five years. It includes information on the overview of the global Factor VIII deficiency treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the Factor VIII deficiency treatment market focus on hemophilia A drugs, hemophilia A inhibitor treatments, and von Willebrand disease treatments, while the segments by application target hospitals, clinics, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, calculating the market size for Factor VIII deficiency treatment. It also includes the market share of major companies in Factor VIII deficiency treatment, product and business overviews, and sales performance.

  • Other services
  • Hemophilia medications

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Hemophilia A and B Treatment Materials

[Research Material] Global Market for Hemophilia A and B Treatment Materials

World Market for Hemophilia A and B Treatment Materials: Desmopressin, Octocog alfa, Nonacog alfa, Others, Dental Clinics, Hospitals, Outpatient Surgery Centers

This research report (Global Hemophilia A and B Therapeutics Materials) investigates and analyzes the current state of the global market for hemophilia A and B therapeutic materials and its outlook for the next five years. It includes information on the global hemophilia A and B therapeutic materials market overview, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include Desmopressin, Octocog alfa, Nonacog alfa, and others, while the segments by application focus on dental clinics, hospitals, and outpatient surgical centers. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for hemophilia A and B therapeutic materials. It also includes the market share of major companies in the hemophilia A and B therapeutic materials market, product and business overviews, and sales performance.

  • Other services
  • Hemophilia medications

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Hemophilia A Treatment Drugs

[Research Material] Global Market for Hemophilia A Treatment Drugs

Global Market for Hemophilia A Treatments: ATXF-8117, BAY-1093884, BIVV-001, BS-027125, Consizumab ...

This research report (Global Hemophilia A Drug Market) investigates and analyzes the current state and outlook for the global market of hemophilia A treatment drugs over the next five years. It includes information on the overview of the global hemophilia A treatment drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the hemophilia A treatment drug market include ATXF-8117, BAY-1093884, BIVV-001, BS-027125, concizumab, CSL-689, and others, while the segments by application focus on clinics, hospitals, and ASCs. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size of hemophilia A treatment drugs. It also includes the market share of major companies in the hemophilia A treatment drug market, product and business overviews, and sales performance.

  • Other services
  • Hemophilia medications

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

Related Categories of Hemophilia medications

COPYRIGHT © 2001-2026 IPROS CORPORATION ALL RIGHTS RESERVED.